TheProfitWatch

SVRA - Savara Inc.

Day 1m 10m 60m PreMarket Market AfterHours Gap
3.38 0.27 (7.99%) --- --- --- -0.06 (-1.78%) 0.21 (6.19%) 0.1 (2.82%) 0.1 (2.82%)

Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.12
Diluted EPS:
-0.12
Basic P/E:
-30.4167
Diluted P/E:
-30.4167
RSI(14) 1m:
100.0
VWAP:
3.65
RVol:
1.3007

Events

Period Kind Movement Occurred At
1m Price increase 1m 3.42 +0.04 (+1.18%) Oct 15 09:32

Related News